SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,644.76 64.22
( 0.09%)

Global Indices

Nasdaq

51,370.81 -161.78
(-0.31%)

Dow Jones

7,725.73 -1.30
(-0.02%)

Hang Seng

65,657.92 638.97
(0.98%)

Nikkei 225

10,680.49 -24.77
(-0.23%)

Forex

USD-INR

95.73 0.08
(0.09%)

EUR-INR

109.20 -0.36
(-0.33%)

GBP-INR

127.12 -0.62
(-0.48%)

JPY-INR

0.61 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kotak Nifty 100 Low Vol 30 ETF

Industry : Stock Exchanges

BSE Code

ISIN Demat

Book Value()

76614

INF174KA1IY5

10.2619886

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LOWVOL1

166.94

EPS(TTM)

Face Value()

Div & Yield %

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter

Aug 03,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 15.69% to Rs 237.18 crore in the quarter ended June 2026 as against Rs 205.01 crore during the previous quarter ended June 2025. Sales rose 16.55% to Rs 938.44 crore in the quarter ended June 2026 as against Rs 805.17 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	938.44	805.17	17
OPM %	31.49	31.20	-
PBDT	338.29	294.50	15
PBT	322.45	278.98	16
NP	237.18	205.01	16

73,644.76 64.22 ( 0.09%)

51,370.81 -161.78 (-0.31%)

7,725.73 -1.30 (-0.02%)

65,657.92 638.97 (0.98%)

10,680.49 -24.77 (-0.23%)

95.73 0.08 (0.09%)

109.20 -0.36 (-0.33%)

127.12 -0.62 (-0.48%)

0.61 0.00 (-0.28%)